Acotec Scientific Holdings Ltd Logo
KYG0096M1096
A3CYF9
6669.HK

Acotec Scientific Holdings Ltd

Loading quotes...

Forecast

There is no analyst data available for this company.

Discussions in the community

There is no discussion about this asset yet.

Start discussion

There is currently no news available for this company. We are working on adding more providers to change this.

Financials

In the last quarter, Acotec Scientific Holdings Ltd had revenue of €21.38m and net profit of -€5.21m
(EUR) June 2026
YoY
Revenue 21.38m 2.82%
Gross profit 15.04m 2.52%
Net profit -5.21m 199.38%
EBITDA -4.27m 178.62%

Fundamentals

Metric Value
Market capitalization
€161.54m
Number of shares
302.83m
52-week high/low
€1.77 - €0.53
Dividends No
Beta
-0.03
P/E ratio
-24.54
PEG ratio
0.16
P/B ratio
0.84
P/S ratio
1.90

Company profile

Acotec Scientific Holdings Limited, a medical device company, researches and develops percutaneous transluminal angioplasty and drug-coated balloon products for the treatment of vascular diseases in Mailand China, Europe, and internationally. It offers AcoArt Orchid & Dhalia to prevent stenosis or occlusion in superficial femoral artery and popliteal artery for the treatment of lower extremity artery disease; under clinical studies in nephrology for arteriovenous fistula stenosis and in neurology for vertebral atherosclerotic stenosis indications/applications; and under clinical studies in andrology for vasculogenic erectile dysfunction indications/applications. The company also provides AcoArt Tulip & Litos, which is under registration process in China and Europe, and under preclinical studies in the United States in vascular surgery for below-the-knee artery disease indications/applications; and in pre-clinical studies in andrology for vasculogenic erectile dysfunction indications/applications. The company was incorporated in 2020 and is headquartered in Beijing, China. Acotec Scientific Holdings Limited is a subsidiary of CA Medtech Investment (Cayman) Limited.

Name
Acotec Scientific Holdings Ltd
CEO
Jing Li
Headquarters Beijing, be
China
Website
IPO
24/08/2021
Employees 955

Ticker symbols

Exchange Symbol
Hkse
6669.HK
Frankfurt
7W3.F
München
7W3.MU
Düsseldorf
7W3.DU
🍪

Parqet  uses cookies. Learn more